Dec 15, 2022 by James HalleyWhy Shares of Puma Biotechnology Rose This WeekThe company's CEO bought $2.5 million worth of company stock.
Dec 14, 2022 by James Halley3 Cannabis Stocks to Buy Before Pennsylvania Approves Adult-Use SalesThese three companies are already established in the Keystone State.
Dec 13, 2022 by James Halley3 Top Cannabis Stocks to Buy for DecemberSometimes the best cannabis stocks are the ones overlooked.
Dec 8, 2022 by James HalleyWhy Shares of Cano Health Are Slumping This WeekConcerns about the company's liquidity may be driving some investors away.
Dec 8, 2022 by James HalleyWhy Shares of Alvotech Jumped This WeekThe Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe.
Dec 8, 2022 by James HalleyWhy Shares of Prometheus Biosciences Are Soaring This WeekThe clinical-stage biotech that specializes in IBD therapies announced positive news regarding two trials for its lead therapy.
Dec 8, 2022 by James Halley3 Revolutionary Stocks I'd Buy Right Now Without HesitationThe three companies are changing the pharmaceutical industry.
Dec 8, 2022 by James Halley3 Hot Stocks That Could Live Up to Their Lofty ValuationsThese companies have long runways of growth ahead
Dec 7, 2022 by James HalleyWhy Shares of Mirati Therapeutics Fell WednesdayThe company presented phase 2 data from its non-small cell lung cancer therapy.
Dec 7, 2022 by James HalleyWhy Curaleaf's Shares Are Down WednesdayThe company's stock fell in tandem with other cannabis companies.
Dec 6, 2022 by James HalleyWhy Shares of Nutex Health Jumped 17.99% on TuesdayThe technology-enabled healthcare management company is up more than 210% this past month.
Dec 6, 2022 by James HalleyWhy Shares of Mirati Therapeutics Fell TuesdayInvestors and analysts were unimpressed by trial results on the company's combination therapy to treat non-small cell lung cancer.
Dec 6, 2022 by James HalleyWhy BioVie's Shares Tumbled TuesdayThe clinical-stage biotech released data on its prospective Alzheimer's therapy.
Dec 6, 2022 by James HalleyBetter Buy: Tilray or Innovative Industrial Properties?One appears to be a better short-term choice, the other for the long term.
Dec 6, 2022 by James HalleyIs AbbVie Stock a Buy Now?The pharmaceutical company prepared well as Humira approaches its patent cliff next year.
Dec 5, 2022 by James HalleyWhy Shares of Editas Medicine Dropped 15.5% in NovemberThe biotech's shares plummeted after it paused a key clinical trial.
Dec 5, 2022 by James HalleyWhy Shares of Provention Bio Went Up 30.3% in NovemberThe company got approval for its lead type 1 diabetes therapy.
Dec 5, 2022 by James HalleyIf You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have TodayThe stock for this healthcare stalwart beat the S&P 500's performance over the past decade.
Dec 4, 2022 by James HalleyWhy Cano Health's Shares Dropped 46.9% in NovemberLowered guidance and big third-quarter losses worried investors.
Dec 2, 2022 by James HalleyWhy Shares of Agenus Rose 12.5% on FridayAgenus presented data this week on a combination therapy.
